Early Detection

Treatment Efficacy Survival Rates Cost Reduction Diagnostic Tools Care Coordination Quality of Life

Mount Sinai Rolls Out FDA-Cleared BrightHeart AI for Fetal Ultrasounds Across Manhattan

Peer-reviewed results show AI assistance pushed detection of suspicious major heart defects above 97%, with faster reads and higher clinician confidence.